Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
Life science companies and a record number of investors gathered at NLS Days 2026 to present research data, establish business partnerships, and secure capital. The event served as a platform for stakeholders to engage in dealmaking activities within the Nordic life sciences sector.
Participants utilized the conference to showcase clinical and scientific findings while facilitating discussions regarding potential collaborations. The high turnout of investors marked a notable increase in attendance compared to previous years, reflecting current engagement levels in the regional market. These interactions focused on the exchange of information between emerging firms and financial backers to support ongoing development and funding initiatives.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: September 11, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]






